Lakeview Capital Partners LLC lessened its holdings in shares of Metlife Inc (NYSE:MET) by 12.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,585 shares of the financial services provider’s stock after selling 647 shares during the period. Lakeview Capital Partners LLC’s holdings in Metlife were worth $216,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in MET. New England Research & Management Inc. acquired a new stake in shares of Metlife in the 3rd quarter worth approximately $894,000. Daiwa Securities Group Inc. boosted its holdings in shares of Metlife by 1.8% during the 3rd quarter. Daiwa Securities Group Inc. now owns 39,032 shares of the financial services provider’s stock worth $1,841,000 after buying an additional 696 shares during the period. Symmetry Partners LLC bought a new stake in shares of Metlife during the 3rd quarter worth $727,000. Bartlett & Co. LLC boosted its holdings in shares of Metlife by 4,792.7% during the 3rd quarter. Bartlett & Co. LLC now owns 327,564 shares of the financial services provider’s stock worth $15,448,000 after buying an additional 320,869 shares during the period. Finally, Tibra Equities Europe Ltd bought a new stake in shares of Metlife during the 3rd quarter worth $18,072,000. 75.59% of the stock is owned by institutional investors and hedge funds.
MET has been the subject of a number of research reports. ValuEngine raised shares of Metlife from a “strong sell” rating to a “sell” rating in a report on Monday, November 4th. Zacks Investment Research downgraded shares of Metlife from a “hold” rating to a “sell” rating and set a $51.00 price target for the company. in a report on Wednesday. Morgan Stanley reduced their price target on shares of Metlife from $54.00 to $53.00 and set an “equal weight” rating for the company in a report on Tuesday, August 20th. UBS Group increased their price target on shares of Metlife from $46.00 to $47.00 and gave the company a “neutral” rating in a report on Thursday, October 10th. Finally, Citigroup reduced their price target on shares of Metlife from $42.00 to $41.00 and set a “sell” rating for the company in a report on Friday, September 13th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the stock. Metlife currently has an average rating of “Hold” and an average price target of $49.51.
Metlife (NYSE:MET) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $1.27 earnings per share for the quarter, missing analysts’ consensus estimates of $1.40 by ($0.13). Metlife had a net margin of 10.82% and a return on equity of 8.82%. The company had revenue of $16.92 billion during the quarter, compared to the consensus estimate of $16.37 billion. During the same period last year, the company earned $1.38 earnings per share. Metlife’s revenue for the quarter was up 3.2% on a year-over-year basis. On average, analysts predict that Metlife Inc will post 5.55 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Tuesday, November 5th will be paid a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.57%. The ex-dividend date is Monday, November 4th. Metlife’s dividend payout ratio is 32.65%.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Further Reading: What is Call Option Volume?
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.